Cell Type Specific Transcriptional Cascades in Inner Ear Development
Cell Type Specific Transcriptional Cascades in Inner Ear Development
批准号:
10115979
负责人:
Ronna Hertzano
金额:
$62.51万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-03-01 至 2025-11-30
关键词:
AddressAgeBioinformaticsBiologicalCandidate Disease GeneCell Differentiation processCell SurvivalCellsCellular biologyCochleaCommunitiesDataData SetDefectDevelopmentDiseaseEarEmbryoEpidemicEpigenetic ProcessEquilibriumFundingFutureGFI1 geneGene ExpressionGene Expression ProfilingGenesGeneticGenetic TranscriptionGenetic studyGenomicsGoalsGrantHairHair CellsHearingHourHumanInformaticsInternationalInterventionKnockout MiceKnowledgeLabyrinthLeadLettersMaintenanceMapsModelingMolecularMusMutagenesisNamesNoise-Induced Hearing LossOuter Hair CellsPathologyPathway interactionsPhenotypePlayPopulationPresbycusisProcessProductionProtocols documentationRFX1RFX3Regulator GenesResearchResearch PersonnelRiboTagRoleRouteSensorySensory HairSignal PathwaySignal TransductionSignaling ProteinTestingTherapeutic InterventionVestibular Hair CellsVisualizationWorkZebrafishage relatedbasecell typecilium biogenesisconditional knockoutdesignfollow-uphair cell regenerationhearing impairmentinner ear developmentmolecular targeted therapiesmouse modelmultiple omicsnovelpostnatalpreventprogramsregenerative therapystemstem cell fatestem cellssuccesstooltranscription factortranscriptomicstranslatome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Disabling age-related hearing loss (ARHL) afflicts greater than 50% of the population over the age of 70.
The progressive loss of sensory hair cells (HCs) of the cochlea, primarily the outer HCs (OHCs), is either the
cause or the final common pathology of most forms of ARHL. However, the molecular basis of ARHL is
unknown, impeding development of targeted interventions. Furthermore, attempts to reprogram progenitor
cells towards cochlear HC fates result primarily in immature HC-like cells, similar to vestibular HCs. For these
reasons, the study of the molecular pathways underlying OHC differentiation and survival is critical.
Transcription factors (TFs) are key regulators of gene expression. When associated with disease,
identifying the upstream regulators and downstream targets of a TF is an effective route to determine
additional key players in the same process. In this competitive renewal we build upon our previous success,
identifying critical roles for the RFX and IKZF2 TFs in OHC differentiation, function and survival, and follow up
with two specific aims designed to elucidate their molecular mechanism within the HC/OHC genetic programs:
Group 1 RFX TFs (RFX1/2/3), are master regulators of ciliogenesis. However, while OHCs lacking Rfx1/3
die within 12 hours from the onset of hearing, they have normal bundle development. RFX2 is transiently
expressed in the developing HCs, possibly preventing a ciliogenesis defect with loss of Rfx1/3. We therefore
hypothesize that group 1 RFX TFs have a dual role in HC development, with an early role in hair bundle
formation, and later role in terminal differentiation and survival. Specific Aim 1: To identify the mechanisms by
which RFX TFs support embryonic as well as early post-natal cochlear hair cell differentiation.
IKZF2 is a key regulator of OHC gene expression, precisely regulated to express only in OHCs starting
from P4. We hypothesize that: (1) deletion of IKZF2 target genes will reveal genes essential for OHC function
and survival; (2) IKZF2 is required for maintenance of mature OHCs; and (3) Ikzf2 expression is regulated by a
master-regulator of OHC maturation. Specific Aim 2: To identify the mechanism by which IKZF2 leads to OHC
differentiation, to determine its role in mature OHCs, and to identify its upstream regulatory network.
To accomplish these aims we combine novel protocols for OHC-specific multi-omic analyses with state-
of-the-art bioinformatics, and characterization of novel mouse models to validate the roles of candidate genes
in hearing. Successful completion of these aims will: (1) impact our understanding of OHC differentiation and
survival; (2) functionally characterize the roles of key RFX and IKZF2 target genes in hearing; (3) result in
transcriptomic and epigenetic maps of differentiating and mature OHCs which will be applied to inform
studies for HC regeneration/identifying candidate genes for ARHL; and (4) generate numerous mouse models
for RFX and IKZF2 target genes, which will be readily available to the scientific community. Additionally, all of
the data generated as part of this proposal will be shared via the gEAR (umgear.org).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing FAIRness and TRUST in the gEAR portal
-
批准号:10408360
-
项目类别:
-
资助金额:$22.59万
-
财政年份:2021
-
负责人:Ronna Hertzano
-
依托单位:
The gEAR portal - Advancing Data Sharing, Analysis and Discovery for Hearing and Balance Research
-
批准号:10181299
-
项目类别:
-
资助金额:$65.21万
-
财政年份:2021
-
负责人:Ronna Hertzano
-
依托单位:
Illuminating Neurodevelopment through Integrated Analysis and Vizualization of Multi-Omic Data
-
批准号:9766403
-
项目类别:
-
资助金额:$63.52万
-
财政年份:2018
-
负责人:Ronna Hertzano
-
依托单位:
Illuminating Neurodevelopment through Integrated Analysis and Vizualization of Multi-Omic Data
-
批准号:9927668
-
项目类别:
-
资助金额:$63.52万
-
财政年份:2018
-
负责人:Ronna Hertzano
-
依托单位:
Cell Type Specific Transcriptional Cascades in Inner Ear Development
-
批准号:8886739
-
项目类别:
-
资助金额:$47.28万
-
财政年份:2015
-
负责人:Ronna Hertzano
-
依托单位:
Cell Type Specific Transcriptional Cascades in Inner Ear Development
-
批准号:9017994
-
项目类别:
-
资助金额:$51.87万
-
财政年份:2015
-
负责人:Ronna Hertzano
-
依托单位:
Cell Type Specific Transcriptional Cascades in Inner Ear Development
-
批准号:9263957
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2015
-
负责人:Ronna Hertzano
-
依托单位:
Cell Type Specific Transcriptional Cascades in Inner Ear Development
-
批准号:10308548
-
项目类别:
-
资助金额:$59.78万
-
财政年份:2015
-
负责人:Ronna Hertzano
-
依托单位:
Space Activation for Ronna Hertzano Lab
-
批准号:10916888
-
项目类别:
-
资助金额:$199.96万
-
财政年份:--
-
负责人:Ronna Hertzano
-
依托单位:
Clinical Analysis of Disorders of Hearing and Balance
-
批准号:10923706
-
项目类别:
-
资助金额:$203.74万
-
财政年份:--
-
负责人:Ronna Hertzano
-
依托单位:
Multi-Omic and Functional Analyses for Hearing Preservation and Restoration
-
批准号:10916871
-
项目类别:
-
资助金额:$199.96万
-
财政年份:--
-
负责人:Ronna Hertzano
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: